Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Kevin G Lafond Net Worth & Insider Trades

Kevin G Lafond - SVP, Ziopharm Oncology Inc

As of January 12, 2021

What is Kevin G Lafond's Net Worth?

The current estimated net worth of Ziopharm Oncology Inc's SVP, Kevin G Lafond, is estimated to be about $1.06M . Kevin G Lafond owns about 63,965 units of Ziopharm Oncology Inc common stock. In the last 8 years at Ziopharm Oncology Inc, Kevin G Lafond has sold an estimated value of $838.69K worth.

What is Kevin G Lafond's Past Insider Trading?

Kevin G Lafond's largest purchase order was 30,834 units , worth over $65.92K on June 5, 2015. Kevin G Lafond's largest sale order was 57,500 units , worth over $555.08K on June 5, 2015. In total, Kevin G Lafond has made about 9 transactions over 8 years of their time at Ziopharm Oncology Inc. Kevin G Lafond usually trades in January, with the busiest year in 2019. The most recent transaction was a sale order of 18,020 units , worth over $55.68K on January 12, 2021.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Kevin G Lafond

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Kevin G Lafond's' Mailing Address?

  • Mailing address is C/o Helicos Biosciences Corporation 1 Kendall Square, Building 700 Cambridge MA 02139 MA

What are Ziopharm Oncology Inc's Past Insider Trades?

Ziopharm Oncology Inc's most recent insider trade came on December 27, 2021 by Eleanor de Groot who sold 20,132 units worth $25.57K . In the last 14 years, insiders at Ziopharm Oncology Inc have sold an estimated value of $13.56M and bought an estimated value of $76.75M worth of shares. Insider trading is most common in January, with the busiest year in 2017. The most active traders at the company are Randal Kirk, Director,  Intrexon Corp,  and Anthony James Cannon, Director .

ZIOPHARM ONCOLOGY INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...